2-Iodo-5-nitropyridine, 97%, 5g

2-(9,9-Diphenyl-9H-fluoren-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 10g

3-(Dimethylamino)propiophenone Hydrochloride, 98.0%, 5g

2-(2-Chloro-6-fluorophenyl)ethanol, 95.0%, 25g

2-{8-[(tert-butoxy)carbonyl]-8-azabicyclo[3.2.1]octan-3-yl}acetic acid, 98%, 1g

methyl (5,6-dimethyl-1H-benzimidazol-2-yl)acetate, 1g

4-nitrofenil-beta-D-xiloside, minimo 99%, per biochimica, 1 g, confezione in vetro

(1R,2R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)cyclobutane-1-carboxylic acid, 97%, 100mg

4-Aminocarbonylphenylboronic acid, 96.0%, 1g

2,5-dioxopyrrolidin-1-yl 4-((5-nitropyridin-2-yl)disulfanyl)butanoate, 98%, 25mg

Nefazodone Hydrochloride>98.0%(HPLC)(T)200mg

(R)-tert-Butyl (4-oxobutan-2-yl)carbamate, 97.0%, 250mg

Dodecylbenzenesulfonyl Azide (soft type) (mixture)25g